AIA Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
AIA Group's BIIB Position: Q1 2026 in Review
AIA Group increased its Biogen (BIIB) stake by 310% in Q1 2026, buying an estimated $1.3M and bringing the position to 9,329 shares worth $1.71M. The position accounts for 0.02% of the portfolio, ranked #225.
AIA Group first reported a position in BIIB in Q4 2020 and has held it in 20 quarters since. The position peaked at $3.1M in Q3 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- AIA Group held 9,329 shares of Biogen worth $1.71M as of Q1 2026.
- AIA Group bought 7,054 Biogen shares in Q1 2026, an estimated $1.3M.
- Biogen made up 0.02% of AIA Group's portfolio in Q1 2026, its #225 holding.
- AIA Group first reported a position in Biogen in Q4 2020 and has held it in 20 quarters since.
- AIA Group's Biogen position peaked at $3.1M in Q3 2025.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.